Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

An examination of the Boston Naming Test: calculation of "estimated" 60-item score from 30- and 15-item scores in a cognitively impaired population.

Hobson VL, Hall JR, Harvey M, Cullum CM, Lacritz L, Massman PJ, Waring SC, O'Bryant SE.

Int J Geriatr Psychiatry. 2011 Apr;26(4):351-5. doi: 10.1002/gps.2533.

PMID:
20690129
2.

Boston Naming Test: shortened versions for use in Alzheimer's disease.

Mack WJ, Freed DM, Williams BW, Henderson VW.

J Gerontol. 1992 May;47(3):P154-8.

PMID:
1573197
3.

Boston Naming Test in Alzheimer's disease.

Williams BW, Mack W, Henderson VW.

Neuropsychologia. 1989;27(8):1073-9.

PMID:
2797414
4.

Confrontation naming does not add incremental diagnostic utility in MCI and Alzheimer's disease.

Testa JA, Ivnik RJ, Boeve B, Petersen RC, Pankratz VS, Knopman D, Tangalos E, Smith GE.

J Int Neuropsychol Soc. 2004 Jul;10(4):504-12.

PMID:
15327729
5.

Boston naming test short forms: a comparison of previous forms with new item response theory based forms.

Graves RE, Bezeau SC, Fogarty J, Blair R.

J Clin Exp Neuropsychol. 2004 Oct;26(7):891-902.

PMID:
15742540
6.

The 60-item Boston Naming Test: norms for cognitively intact adults aged 25 to 88 years.

Tombaugh TN, Hubley AM.

J Clin Exp Neuropsychol. 1997 Dec;19(6):922-32.

PMID:
9524887
7.

[A shortened form of the Spanish Boston naming test: a useful tool for the diagnosis of Alzheimer's disease].

Serrano C, Allegri RF, Drake M, Butman J, Harris P, Nagle C, Ranalli C.

Rev Neurol. 2001 Oct 1-15;33(7):624-7. Spanish.

8.

Longitudinal cognitive decline in patients with Alzheimer's disease.

Rebok G, Brandt J, Folstein M.

J Geriatr Psychiatry Neurol. 1990 Apr-Jun;3(2):91-7.

PMID:
2206264
9.

Odd/Even short forms of the Boston Naming Test: preliminary geriatric norms.

Fisher NJ, Tierney MC, Snow WG, Szalai JP.

Clin Neuropsychol. 1999 Aug;13(3):359-64.

PMID:
10726606
10.

Dementia does not explain correlation between age and scores on Boston Naming Test.

Mackay A, Connor LT, Storandt M.

Arch Clin Neuropsychol. 2005 Jan;20(1):129-33.

11.

A cross-sectional study of the effects of age, education, and gender on the Boston Naming Test.

Zec RF, Burkett NR, Markwell SJ, Larsen DL.

Clin Neuropsychol. 2007 Jul;21(4):587-616.

PMID:
17613980
12.

Item analysis of ADAS-Cog: effect of baseline cognitive impairment in a clinical AD trial.

Sevigny JJ, Peng Y, Liu L, Lines CR.

Am J Alzheimers Dis Other Demen. 2010 Mar;25(2):119-24. doi: 10.1177/1533317509350298.

PMID:
19949163
13.

The diagnostic accuracy of an incidental memory modification of the Boston Naming Test (memo-BNT) in differentiating between normal aging and mild Alzheimer's disease.

Karrasch M, Myllyniemi A, Latvasalo L, Söderholm C, Ellfolk U, Laine M.

Clin Neuropsychol. 2010 Nov;24(8):1355-64. doi: 10.1080/13854046.2010.521982. Epub 2010 Oct 20.

PMID:
20967687
14.

[Validation of the Rapid BAttery of Denomination (BARD) in 382 controls and 1004 patients of a memory clinic].

Croisile B, Astier JL, Beaumont C, Mollion H.

Rev Neurol (Paris). 2010 Jun-Jul;166(6-7):584-93. doi: 10.1016/j.neurol.2010.01.017. Epub 2010 Mar 11. French.

PMID:
20226490
15.

Mini-Mental Status Examination: mixed Rasch model item analysis derived two different cognitive dimensions of the MMSE.

Schultz-Larsen K, Kreiner S, Lomholt RK.

J Clin Epidemiol. 2007 Mar;60(3):268-79. Epub 2006 Aug 10.

PMID:
17292021
16.

[Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].

Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.

Encephale. 2003 May-Jun;29(3 Pt 1):266-72. French.

PMID:
12876552
17.
18.

The Boston Naming Test in Swedish: normative data.

Tallberg IM.

Brain Lang. 2005 Jul;94(1):19-31. Epub 2005 Jan 7.

PMID:
15896380
19.

Awareness of cognitive deficits and anosognosia in probable Alzheimer's disease.

Lopez OL, Becker JT, Somsak D, Dew MA, DeKosky ST.

Eur Neurol. 1994;34(5):277-82.

PMID:
7995303
20.

Profiles of neuropsychological impairment in autopsy-defined Alzheimer's disease and cerebrovascular disease.

Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C, Jagust WJ, Chui HC.

Brain. 2007 Mar;130(Pt 3):731-9. Epub 2007 Jan 31.

PMID:
17267522

Supplemental Content

Support Center